Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018
Open Access
- 27 January 2025
- journal article
- letter
- Published by Wiley in HemaSphere
- Vol. 9 (1) , e70080
Abstract
No abstract availableFunding Information
- Fru Berta Kamprads Stiftelse (FBKS‐2022‐17 ‐ (371))
This publication has 12 references indexed in Scilit:
- Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete ProjectHemaSphere, 2023
- Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020British Journal of Haematology, 2022
- Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)Journal of Hematology & Oncology, 2017
- Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2017
- Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)Annals of Oncology, 2017
- Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma NetworkJournal of Clinical Oncology, 2016
- Radiation Therapy Is an Effective Modality in the Treatment of Mantle Cell Lymphoma, Even in Heavily Pretreated PatientsClinical Lymphoma Myeloma and Leukemia, 2014
- Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret HospitalLeukemia & Lymphoma, 2012
- Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma GroupBlood, 2008
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987